The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Pancreatic cancer has one of the bleakest survival rates in oncology. Just 13% of patients are alive five years after ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
A new liquid biopsy test using artificial intelligence models could help spot a rare type of bone and soft tissue cancer that ...
This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced ...
The dogs are detecting changes in volatile organic compounds — substances produced by the body when diseases like cancer are ...